Structural Insight into the role of Inhibitor Peptide derived from Tumstatin-Integrin Complex in Inhibitory Mechanism: A Molecular Dynamics Simulations Study

Ghorbani, Mohammad; Taghdir, Majid

Structural Insight into the role of Inhibitor Peptide derived from Tumstatin-Integrin Complex in Inhibitory Mechanism: A Molecular Dynamics Simulations Study

Document Type : Original Research

Authors

mohammad ghorbani

Majid Taghdir

Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Abstract

Integrin inhibitors may change conformational and dynamical properties of integrin, but its molecular properties in this process is not clearly understood. Tumstatin is an anti-angiogenesis protein derived from collagen XVIII, but little is known about how tumstatin applies its antiangiogenic and antitumor effects. It has been reported that 18 amino acids fragment of tumstatin has anti-tumor activities similar to tumstatin. We used molecular docking and molecular dynamic simulations to describe inhibitor activity of peptide in molecular level. We described the binding of this peptide to Hybrid/EGF-4 interface and that these interactions might contribute to improved hydrophobic interactions at these regions and also fixed the mobile domains of integrin. In the complex, we recognized a novel binding site on integrin for integrin inhibitors that may have critical role in integrin inhibition. These results support the idea that hydrophobic interactions between Hybrid/EGF-4 domain and peptide-anti tumor might contribute to stability of bended state and therefore inhibit integrin activation. Our finding can be applied to understand the mechanism of out-in pathway integrin signaling and development of integrin targeted drug.

Keywords

Tumstatin

anti-angiogenesis

Integrin

Molecular dynamic

20.1001.1.23222115.1399.11.2.13.4

Subjects

Pharmaceutical Biotechnology

1. Mehrbod, M., S. Trisno, and M.R. Mofrad, On the activation of integrin αIIbβ3: outside-in and inside-out pathways. Biophysical journal, 2013. 105(6): p. 1304-1315.
2. Xiong, J., H.E. Balcioglu, and E.H. Danen, Integrin signaling in control of tumor growth and progression. The international journal of biochemistry & cell biology, 2013. 45(5): p. 1012-1015.
3. Morse, E.M., N.N. Brahme, and D.A. Calderwood, Integrin cytoplasmic tail interactions. Biochemistry, 2014. 53(5): p. 810-820.
4. Springer, T.A., J. Zhu, and T. Xiao, Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin αIIbβ3. The Journal of cell biology, 2008. 182(4): p. 791-800.
5. Shattil, S.J., C. Kim, and M.H. Ginsberg, The final steps of integrin activation: the end game. Nature reviews Molecular cell biology, 2010. 11(4): p. 288.
6. Chen, W., et al., Molecular dynamics simulations of forced unbending of integrin αVβ3. PLoS computational biology, 2011. 7(2): p. e1001086.
7. Eikesdal, H.P., et al., Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. Proceedings of the National Academy of Sciences, 2008. 105(39): p. 15040-15045.
8. Paladino, A., et al., High affinity vs. native fibronectin in the modulation of αvβ3 integrin conformational dynamics: Insights from computational analyses and implications for molecular design. PLoS computational biology, 2017. 13(1): p. e1005334.
9. Monteiro Torres, P.H., G. Limaverde Soares Costa Sousa, and P.G. Pascutti, Structural analysis of the N‐terminal fragment of the antiangiogenic protein endostatin: A molecular dynamics study. Proteins: Structure, Function, and Bioinformatics, 2011. 79(9): p. 2684-2692.
10. He, G.-A., et al., Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. Biochemical and biophysical research communications, 2003. 312(3): p. 801-805.
11. Comeau, S.R., et al., ClusPro: a fully automated algorithm for protein–protein docking. Nucleic acids research, 2004. 32(suppl_2): p. W96-W99.
12. De Vries, S.J., M. Van Dijk, and A.M. Bonvin, The HADDOCK web server for data-driven biomolecular docking. Nature protocols, 2010. 5(5): p. 883.
13. DeLano, W.L., The PyMOL molecular graphics system. http://www. pymol. org, 2002.
14. Lindahl, E., B. Hess, and D. Van Der Spoel, GROMACS 3.0: a package for molecular simulation and trajectory analysis. Molecular modeling annual, 2001. 7(8): p. 306-317.
15. Essmann, U., et al., A smooth particle mesh Ewald method. The Journal of chemical physics, 1995. 103(19): p. 8577-8593.
16. Danhier, F., A. Le Breton, and V.r. Préat, RGD-based strategies to target alpha (v) beta (3) integrin in cancer therapy and diagnosis. Molecular pharmaceutics, 2012. 9(11): p. 2961-2973.
17. Kapp, T.G., et al., A comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins. Scientific reports, 2017. 7: p. 39805.